Digi.Bio
Amsterdam
About Digi.Bio
Digi.Bio is accelerating the development of life saving cell therapies with a lab-on-a-chip and computational platform that analyzes how cell therapies perform and evaluate their outcome down to the single cell level, delivering high content results in 24 hours and with minimal material waste.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $343.2K
- Funding stage: Seed
- Last round: Convertible Note (Oct 2021)
- Website: digi.bio
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Information Technology, Software
Social Profiles
Canonical: https://fsome.com/organization/digi-bio-115971 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.